This is an observer-blinded, three-arms study in 376 patients in Chinese individuals aged from 18 to 55 years old who had previously received three doses COVID-19 vaccine. Immunogenicity in terms of ...

A recent study published in the journal Science discussed variant-adapted boosters for coronavirus disease 2019 (COVID-19). Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19), is an enveloped virion containing a positive-sense single strand of ...

Moderna said on Wednesday its bivalent Covid-19 vaccine booster that contained a vaccine targeting the Omicron variant showed a stronger immune response against the variant. Moderna said on Wednesday ...

Current data reveals no significant differences in the antibody responses to the XBB.1 variant of SARS-CoV-2 between the BA.4/BA.5 and BA.1 vaccines. While the precise formulation of future vaccine ...

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains ...

This and subsequent approvals were based on nonrandomized, open-label trials of Omicron-containing boosters that indicated superior immunogenicity against the new variants compared with the original ...

On August 31, 2022, the Food and Drug Administration (FDA) authorized the use of updated COVID-19 booster shots that are specifically tailored to combat the 2 most recent and contagious Omicron ...

The federal Food and Drug Administration has authorized updated COVID-19 boosters that are a better match for the current circulating coronavirus strains. The new boosters from Pfizer-BioNTech and ...

The United Kingdom has become the first country to approve an updated version of Moderna's Covid-19 vaccine booster that targets two coronavirus variants: the Omicron strain and the original virus ...